(BLMN) Bloomin Brands - Ratings and Ratios
Steakhouse, Italian Grill, Seafood, Steakhouse/Wine
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.63% |
| Yield on Cost 5y | 2.83% |
| Yield CAGR 5y | 48.02% |
| Payout Consistency | 77.3% |
| Payout Ratio | 42.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 50.7% |
| Value at Risk 5%th | 76.3% |
| Relative Tail Risk | -8.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -60.63 |
| CAGR/Max DD | -0.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.412 |
| Beta | 1.438 |
| Beta Downside | 1.312 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.05% |
| Mean DD | 35.66% |
| Median DD | 34.10% |
Description: BLMN Bloomin Brands December 25, 2025
Bloomin’ Brands, Inc. (NASDAQ: BLMN) operates a portfolio of four restaurant concepts-Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse & Wine Bar-through both company-owned and franchised locations in the United States and abroad. The firm is organized into U.S. and International Franchise segments and is headquartered in Tampa, Florida.
Recent quarterly data (Q2 2024) show same-store sales up 3.2% year-over-year, franchise royalty revenue rising 5.8% on a 4.1% increase in net unit growth, and an adjusted EBITDA margin of 12.5%, reflecting steady operational leverage despite higher labor costs.
Key drivers for the casual-to-fine dining sector include consumer discretionary spending trends, which are sensitive to employment levels and inflation; rising food commodity prices that compress margins; and the continued shift toward franchising, which lowers capital intensity and improves cash conversion.
For a deeper dive into Bloomin’ Brands’ valuation dynamics, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-57.7m TTM) > 0 and > 6% of Revenue (6% = 214.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 4.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.14% (prev -13.30%; Δ 1.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 277.3m > Net Income -57.7m (YES >=105%, WARN >=100%) |
| Net Debt (2.14b) to EBITDA (214.7m) ratio: 9.98 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (85.1m) change vs 12m ago -1.24% (target <= -2.0% for YES) |
| Gross Margin 44.75% (prev 14.90%; Δ 29.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.6% (prev 128.8%; Δ -22.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.07 (EBITDA TTM 214.7m / Interest Expense TTM 51.2m) >= 6 (WARN >= 3) |
Altman Z'' -1.98
| (A) -0.13 = (Total Current Assets 340.0m - Total Current Liabilities 774.4m) / Total Assets 3.28b |
| (B) -0.28 = Retained Earnings (Balance) -904.1m / Total Assets 3.28b |
| (C) 0.02 = EBIT TTM 54.6m / Avg Total Assets 3.36b |
| (D) -0.31 = Book Value of Equity -895.6m / Total Liabilities 2.93b |
| Total Rating: -1.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.12
| 1. Piotroski 3.50pt |
| 2. FCF Yield 4.82% |
| 3. FCF Margin 3.65% |
| 4. Debt/Equity 6.42 |
| 5. Debt/Ebitda 9.98 |
| 6. ROIC - WACC (= 1.79)% |
| 7. RoE -18.37% |
| 8. Rev. Trend -43.64% |
| 9. EPS Trend -63.42% |
What is the price of BLMN shares?
Over the past week, the price has changed by -1.88%, over one month by -4.90%, over three months by -6.22% and over the past year by -42.23%.
Is BLMN a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 10
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the BLMN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.7 | 13% |
| Analysts Target Price | 7.7 | 13% |
| ValueRay Target Price | 6.3 | -7.8% |
BLMN Fundamental Data Overview December 24, 2025
P/E Trailing = 18.6667
P/E Forward = 7.7042
P/S = 0.1449
P/B = 1.7138
P/EG = 1.07
Beta = 1.131
Revenue TTM = 3.58b USD
EBIT TTM = 54.6m USD
EBITDA TTM = 214.7m USD
Long Term Debt = 962.2m USD (from longTermDebt, last quarter)
Short Term Debt = 179.9m USD (from shortTermDebt, last quarter)
Debt = 2.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.14b USD (from netDebt column, last quarter)
Enterprise Value = 2.72b USD (572.7m + Debt 2.21b - CCE 66.5m)
Interest Coverage Ratio = 1.07 (Ebit TTM 54.6m / Interest Expense TTM 51.2m)
FCF Yield = 4.82% (FCF TTM 130.8m / Enterprise Value 2.72b)
FCF Margin = 3.65% (FCF TTM 130.8m / Revenue TTM 3.58b)
Net Margin = -1.61% (Net Income TTM -57.7m / Revenue TTM 3.58b)
Gross Margin = 44.75% ((Revenue TTM 3.58b - Cost of Revenue TTM 1.98b) / Revenue TTM)
Gross Margin QoQ = 70.38% (prev 70.24%)
Tobins Q-Ratio = 0.83 (Enterprise Value 2.72b / Total Assets 3.28b)
Interest Expense / Debt = 0.50% (Interest Expense 11.1m / Debt 2.21b)
Taxrate = -5.63% (negative due to tax credits) (2.40m / -42.7m)
NOPAT = 57.7m (EBIT 54.6m * (1 - -5.63%)) [negative tax rate / tax credits]
Current Ratio = 0.44 (Total Current Assets 340.0m / Total Current Liabilities 774.4m)
Debt / Equity = 6.42 (Debt 2.21b / totalStockholderEquity, last quarter 344.1m)
Debt / EBITDA = 9.98 (Net Debt 2.14b / EBITDA 214.7m)
Debt / FCF = 16.39 (Net Debt 2.14b / FCF TTM 130.8m)
Total Stockholder Equity = 314.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.76% (Net Income -57.7m / Total Assets 3.28b)
RoE = -18.37% (Net Income TTM -57.7m / Total Stockholder Equity 314.4m)
RoCE = 4.28% (EBIT 54.6m / Capital Employed (Equity 314.4m + L.T.Debt 962.2m))
RoIC = 4.54% (NOPAT 57.7m / Invested Capital 1.27b)
WACC = 2.75% (E(572.7m)/V(2.78b) * Re(11.31%) + D(2.21b)/V(2.78b) * Rd(0.50%) * (1-Tc(-0.06)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.96%
[DCF Debug] Terminal Value 57.30% ; FCFE base≈130.8m ; Y1≈85.9m ; Y5≈39.3m
Fair Price DCF = 5.83 (DCF Value 497.1m / Shares Outstanding 85.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -63.42 | EPS CAGR: -48.08% | SUE: 1.38 | # QB: 1
Revenue Correlation: -43.64 | Revenue CAGR: -3.15% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.59 | Chg30d=+0.003 | Revisions Net=-2 | Analysts=11
EPS next Year (2026-12-31): EPS=0.92 | Chg30d=+0.003 | Revisions Net=-8 | Growth EPS=-18.4% | Growth Revenue=+0.4%
Additional Sources for BLMN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle